Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival

Transplant Proc. 1994 Apr;26(2):743-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Cyclosporine / therapeutic use
  • Dogs
  • Graft Survival / drug effects
  • Graft Survival / immunology*
  • Immunoglobulin G / classification
  • Immunoglobulin G / therapeutic use
  • Immunosuppressive Agents / therapeutic use*
  • Islets of Langerhans Transplantation / immunology*
  • Lymphocyte Culture Test, Mixed
  • Mice
  • Mice, Inbred BALB C / immunology
  • Portal Vein
  • T-Lymphocytes / immunology*
  • Transplantation, Heterotopic
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Cyclosporine